HEADER LIGASE 15-JUN-16 5LAY TITLE DISCOVERY OF NEW NATURAL-PRODUCT-INSPIRED SPIRO-OXINDOLE COMPOUNDS AS TITLE 2 ORALLY ACTIVE INHIBITORS OF THE MDM2-P53 INTERACTION: HDM2 (MDM2) IN TITLE 3 COMPLEX WITH COMPOUND 6G COMPND MOL_ID: 1; COMPND 2 MOLECULE: E3 UBIQUITIN-PROTEIN LIGASE MDM2; COMPND 3 CHAIN: A, B, C, D, E, F; COMPND 4 FRAGMENT: TRUNCATED N-TERMINAL DOMAIN; COMPND 5 SYNONYM: DOUBLE MINUTE 2 PROTEIN,HDM2,ONCOPROTEIN MDM2,P53-BINDING COMPND 6 PROTEIN MDM2; COMPND 7 EC: 6.3.2.- SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 OTHER_DETAILS: EXTERNAL KEYWDS VIENNA, PPI, MDM2, HDM2, BI, LIGASE EXPDTA X-RAY DIFFRACTION AUTHOR D.KESSLER,A.GOLLNER REVDAT 3 12-JUN-19 5LAY 1 AUTHOR REMARK REVDAT 2 21-DEC-16 5LAY 1 JRNL REVDAT 1 02-NOV-16 5LAY 0 JRNL AUTH A.GOLLNER,D.RUDOLPH,H.ARNHOF,M.BAUER,S.M.BLAKE,G.BOEHMELT, JRNL AUTH 2 X.L.COCKROFT,G.DAHMANN,P.ETTMAYER,T.GERSTBERGER, JRNL AUTH 3 J.KAROLYI-OEZGUER,D.KESSLER,C.KOFINK,J.RAMHARTER, JRNL AUTH 4 J.RINNENTHAL,A.SAVCHENKO,R.SCHNITZER,H.WEINSTABL, JRNL AUTH 5 U.WEYER-CZERNILOFSKY,T.WUNBERG,D.B.MCCONNELL JRNL TITL DISCOVERY OF NOVEL JRNL TITL 2 SPIRO[3H-INDOLE-3,2'-PYRROLIDIN]-2(1H)-ONE COMPOUNDS AS JRNL TITL 3 CHEMICALLY STABLE AND ORALLY ACTIVE INHIBITORS OF THE JRNL TITL 4 MDM2-P53 INTERACTION. JRNL REF J. MED. CHEM. V. 59 10147 2016 JRNL REFN ISSN 1520-4804 JRNL PMID 27775892 JRNL DOI 10.1021/ACS.JMEDCHEM.6B00900 REMARK 2 REMARK 2 RESOLUTION. 2.71 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0117 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.71 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 87.45 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 21885 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.252 REMARK 3 R VALUE (WORKING SET) : 0.251 REMARK 3 FREE R VALUE : 0.292 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.600 REMARK 3 FREE R VALUE TEST SET COUNT : 806 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.71 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.78 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1304 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.56 REMARK 3 BIN R VALUE (WORKING SET) : 0.3240 REMARK 3 BIN FREE R VALUE SET COUNT : 51 REMARK 3 BIN FREE R VALUE : 0.3750 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4547 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 260 REMARK 3 SOLVENT ATOMS : 98 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 6.66 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.46000 REMARK 3 B22 (A**2) : 0.46000 REMARK 3 B33 (A**2) : -0.70000 REMARK 3 B12 (A**2) : 0.23000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.874 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.373 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.314 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 30.599 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.870 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.826 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4741 ; 0.008 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): 3244 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6464 ; 1.132 ; 2.052 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7823 ; 1.373 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 555 ; 5.334 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 172 ;39.002 ;23.779 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 791 ;13.639 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 19 ;13.838 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 742 ; 0.057 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5054 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 941 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : RESIDUAL ONLY REMARK 4 REMARK 4 5LAY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-JUN-16. REMARK 100 THE DEPOSITION ID IS D_1200000454. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-JUN-13 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 4.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22692 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 87.450 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 6.200 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.16300 REMARK 200 FOR THE DATA SET : 11.8900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.71 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.96 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : 6.70 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.44800 REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.93 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.99 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL, PH 4.5, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/6 REMARK 290 6555 X-Y,X,Z+5/6 REMARK 290 7555 Y,X,-Z+2/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+1/3 REMARK 290 10555 -Y,-X,-Z+1/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+5/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 347.31800 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 173.65900 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 260.48850 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 86.82950 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 434.14750 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 347.31800 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 173.65900 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 86.82950 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 260.48850 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 434.14750 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5, 6 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 6 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER B 17 REMARK 465 SER C 17 REMARK 465 ASN D 111 REMARK 465 SER E 17 REMARK 465 SER F 17 REMARK 465 GLN F 18 REMARK 465 ILE F 19 REMARK 465 PRO F 20 REMARK 465 ALA F 21 REMARK 465 SER F 22 REMARK 465 VAL F 93 REMARK 465 LYS F 94 REMARK 465 ASN F 106 REMARK 465 LEU F 107 REMARK 465 VAL F 108 REMARK 465 VAL F 109 REMARK 465 VAL F 110 REMARK 465 ASN F 111 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS A 31 NZ REMARK 480 LYS A 51 NZ REMARK 480 GLU A 69 CD OE1 OE2 REMARK 480 GLN A 71 CD OE1 NE2 REMARK 480 LYS A 94 CE NZ REMARK 480 LYS A 98 NZ REMARK 480 LYS B 70 CE NZ REMARK 480 ASN B 79 OD1 ND2 REMARK 480 LYS B 94 CE NZ REMARK 480 GLU B 95 CD OE1 OE2 REMARK 480 LYS B 98 CD CE NZ REMARK 480 LYS C 36 CE NZ REMARK 480 LYS C 39 CG CD CE NZ REMARK 480 GLN C 44 CG CD OE1 NE2 REMARK 480 LYS C 51 CE NZ REMARK 480 GLU C 69 OE1 OE2 REMARK 480 GLN C 71 CG CD OE1 NE2 REMARK 480 ILE C 74 CD1 REMARK 480 GLU C 95 CG CD OE1 OE2 REMARK 480 LYS C 98 CD CE NZ REMARK 480 ARG C 105 CZ NH1 NH2 REMARK 480 VAL C 110 CG1 CG2 REMARK 480 LYS D 51 NZ REMARK 480 ARG D 65 NE CZ NH1 NH2 REMARK 480 GLU D 69 OE1 OE2 REMARK 480 LYS D 70 NZ REMARK 480 LYS D 94 CD CE NZ REMARK 480 GLN E 18 CD OE1 NE2 REMARK 480 ILE E 19 CD1 REMARK 480 ARG E 29 CZ NH1 NH2 REMARK 480 LYS E 36 CG CD CE NZ REMARK 480 LYS E 51 CE NZ REMARK 480 GLU E 69 CG CD OE1 OE2 REMARK 480 LYS E 70 CG CD CE NZ REMARK 480 GLN E 71 CG CD OE1 NE2 REMARK 480 ILE E 74 CD1 REMARK 480 SER E 78 OG REMARK 480 ASP E 84 CG OD1 OD2 REMARK 480 LEU E 85 CG CD1 CD2 REMARK 480 LYS E 94 CG CD CE NZ REMARK 480 GLU E 95 CD OE1 OE2 REMARK 480 LYS E 98 CD CE NZ REMARK 480 ARG E 105 CZ NH1 NH2 REMARK 480 GLU F 25 CG CD OE1 OE2 REMARK 480 LEU F 27 CG CD1 CD2 REMARK 480 ARG F 29 NE CZ NH1 NH2 REMARK 480 LYS F 31 CG CD CE NZ REMARK 480 LEU F 35 CG CD1 CD2 REMARK 480 LYS F 36 CG CD CE NZ REMARK 480 LEU F 38 CG CD1 CD2 REMARK 480 LYS F 39 CG CD CE NZ REMARK 480 GLN F 44 CG CD OE1 NE2 REMARK 480 ASP F 46 OD1 OD2 REMARK 480 THR F 47 OG1 CG2 REMARK 480 LYS F 51 CG CD CE NZ REMARK 480 VAL F 53 CG1 CG2 REMARK 480 TYR F 56 CD1 CD2 CE1 CE2 CZ OH REMARK 480 LEU F 57 CD1 CD2 REMARK 480 GLU F 69 CG CD OE1 OE2 REMARK 480 LYS F 70 CG CD CE NZ REMARK 480 GLN F 71 CD OE1 NE2 REMARK 480 GLN F 72 CD OE1 NE2 REMARK 480 ILE F 74 CG1 CG2 CD1 REMARK 480 VAL F 75 CG1 CG2 REMARK 480 LEU F 81 CD1 CD2 REMARK 480 VAL F 88 CG1 CG2 REMARK 480 PHE F 91 CG CD1 CD2 CE1 CE2 CZ REMARK 480 SER F 92 OG REMARK 480 GLU F 95 CG CD OE1 OE2 REMARK 480 ARG F 97 CG CD NE CZ NH1 NH2 REMARK 480 LYS F 98 CG CD CE NZ REMARK 480 ILE F 103 CD1 REMARK 480 TYR F 104 CD1 CD2 CE1 CE2 CZ OH REMARK 480 ARG F 105 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 TYR F 104 CG TYR F 104 CD2 -0.094 REMARK 500 TYR F 104 CG TYR F 104 CD1 0.115 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 TYR F 104 CB - CG - CD2 ANGL. DEV. = 6.7 DEGREES REMARK 500 TYR F 104 CB - CG - CD1 ANGL. DEV. = -6.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 66 47.23 -90.84 REMARK 500 LEU C 66 46.93 -81.76 REMARK 500 CYS C 77 23.41 -141.07 REMARK 500 LEU D 66 49.36 -82.00 REMARK 500 HIS F 73 -56.31 -128.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 204 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6SS A 205 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6SS B 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL C 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6SS C 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 D 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6SS D 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL E 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 E 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6SS E 203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6SS F 201 DBREF 5LAY A 17 111 UNP Q00987 MDM2_HUMAN 17 111 DBREF 5LAY B 17 111 UNP Q00987 MDM2_HUMAN 17 111 DBREF 5LAY C 17 111 UNP Q00987 MDM2_HUMAN 17 111 DBREF 5LAY D 17 111 UNP Q00987 MDM2_HUMAN 17 111 DBREF 5LAY E 17 111 UNP Q00987 MDM2_HUMAN 17 111 DBREF 5LAY F 17 111 UNP Q00987 MDM2_HUMAN 17 111 SEQRES 1 A 95 SER GLN ILE PRO ALA SER GLU GLN GLU THR LEU VAL ARG SEQRES 2 A 95 PRO LYS PRO LEU LEU LEU LYS LEU LEU LYS SER VAL GLY SEQRES 3 A 95 ALA GLN LYS ASP THR TYR THR MET LYS GLU VAL LEU PHE SEQRES 4 A 95 TYR LEU GLY GLN TYR ILE MET THR LYS ARG LEU TYR ASP SEQRES 5 A 95 GLU LYS GLN GLN HIS ILE VAL TYR CYS SER ASN ASP LEU SEQRES 6 A 95 LEU GLY ASP LEU PHE GLY VAL PRO SER PHE SER VAL LYS SEQRES 7 A 95 GLU HIS ARG LYS ILE TYR THR MET ILE TYR ARG ASN LEU SEQRES 8 A 95 VAL VAL VAL ASN SEQRES 1 B 95 SER GLN ILE PRO ALA SER GLU GLN GLU THR LEU VAL ARG SEQRES 2 B 95 PRO LYS PRO LEU LEU LEU LYS LEU LEU LYS SER VAL GLY SEQRES 3 B 95 ALA GLN LYS ASP THR TYR THR MET LYS GLU VAL LEU PHE SEQRES 4 B 95 TYR LEU GLY GLN TYR ILE MET THR LYS ARG LEU TYR ASP SEQRES 5 B 95 GLU LYS GLN GLN HIS ILE VAL TYR CYS SER ASN ASP LEU SEQRES 6 B 95 LEU GLY ASP LEU PHE GLY VAL PRO SER PHE SER VAL LYS SEQRES 7 B 95 GLU HIS ARG LYS ILE TYR THR MET ILE TYR ARG ASN LEU SEQRES 8 B 95 VAL VAL VAL ASN SEQRES 1 C 95 SER GLN ILE PRO ALA SER GLU GLN GLU THR LEU VAL ARG SEQRES 2 C 95 PRO LYS PRO LEU LEU LEU LYS LEU LEU LYS SER VAL GLY SEQRES 3 C 95 ALA GLN LYS ASP THR TYR THR MET LYS GLU VAL LEU PHE SEQRES 4 C 95 TYR LEU GLY GLN TYR ILE MET THR LYS ARG LEU TYR ASP SEQRES 5 C 95 GLU LYS GLN GLN HIS ILE VAL TYR CYS SER ASN ASP LEU SEQRES 6 C 95 LEU GLY ASP LEU PHE GLY VAL PRO SER PHE SER VAL LYS SEQRES 7 C 95 GLU HIS ARG LYS ILE TYR THR MET ILE TYR ARG ASN LEU SEQRES 8 C 95 VAL VAL VAL ASN SEQRES 1 D 95 SER GLN ILE PRO ALA SER GLU GLN GLU THR LEU VAL ARG SEQRES 2 D 95 PRO LYS PRO LEU LEU LEU LYS LEU LEU LYS SER VAL GLY SEQRES 3 D 95 ALA GLN LYS ASP THR TYR THR MET LYS GLU VAL LEU PHE SEQRES 4 D 95 TYR LEU GLY GLN TYR ILE MET THR LYS ARG LEU TYR ASP SEQRES 5 D 95 GLU LYS GLN GLN HIS ILE VAL TYR CYS SER ASN ASP LEU SEQRES 6 D 95 LEU GLY ASP LEU PHE GLY VAL PRO SER PHE SER VAL LYS SEQRES 7 D 95 GLU HIS ARG LYS ILE TYR THR MET ILE TYR ARG ASN LEU SEQRES 8 D 95 VAL VAL VAL ASN SEQRES 1 E 95 SER GLN ILE PRO ALA SER GLU GLN GLU THR LEU VAL ARG SEQRES 2 E 95 PRO LYS PRO LEU LEU LEU LYS LEU LEU LYS SER VAL GLY SEQRES 3 E 95 ALA GLN LYS ASP THR TYR THR MET LYS GLU VAL LEU PHE SEQRES 4 E 95 TYR LEU GLY GLN TYR ILE MET THR LYS ARG LEU TYR ASP SEQRES 5 E 95 GLU LYS GLN GLN HIS ILE VAL TYR CYS SER ASN ASP LEU SEQRES 6 E 95 LEU GLY ASP LEU PHE GLY VAL PRO SER PHE SER VAL LYS SEQRES 7 E 95 GLU HIS ARG LYS ILE TYR THR MET ILE TYR ARG ASN LEU SEQRES 8 E 95 VAL VAL VAL ASN SEQRES 1 F 95 SER GLN ILE PRO ALA SER GLU GLN GLU THR LEU VAL ARG SEQRES 2 F 95 PRO LYS PRO LEU LEU LEU LYS LEU LEU LYS SER VAL GLY SEQRES 3 F 95 ALA GLN LYS ASP THR TYR THR MET LYS GLU VAL LEU PHE SEQRES 4 F 95 TYR LEU GLY GLN TYR ILE MET THR LYS ARG LEU TYR ASP SEQRES 5 F 95 GLU LYS GLN GLN HIS ILE VAL TYR CYS SER ASN ASP LEU SEQRES 6 F 95 LEU GLY ASP LEU PHE GLY VAL PRO SER PHE SER VAL LYS SEQRES 7 F 95 GLU HIS ARG LYS ILE TYR THR MET ILE TYR ARG ASN LEU SEQRES 8 F 95 VAL VAL VAL ASN HET GOL A 201 6 HET GOL A 202 6 HET GOL A 203 6 HET SO4 A 204 5 HET 6SS A 205 35 HET SO4 B 201 5 HET 6SS B 202 35 HET GOL C 201 6 HET 6SS C 202 35 HET SO4 D 201 5 HET 6SS D 202 35 HET GOL E 201 6 HET SO4 E 202 5 HET 6SS E 203 35 HET 6SS F 201 35 HETNAM GOL GLYCEROL HETNAM SO4 SULFATE ION HETNAM 6SS (3~{S},3'~{S},4'~{S},5'~{S})-4'-AZANYL-6-CHLORANYL-3'- HETNAM 2 6SS (3-CHLORANYL-2-FLUORANYL-PHENYL)-1'-[(3-ETHOXYPHENYL) HETNAM 3 6SS METHYL]-5'-METHYL-SPIRO[1~{H}-INDOLE-3,2'- HETNAM 4 6SS PYRROLIDINE]-2-ONE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 7 GOL 5(C3 H8 O3) FORMUL 10 SO4 4(O4 S 2-) FORMUL 11 6SS 6(C27 H26 CL2 F N3 O2) FORMUL 22 HOH *98(H2 O) HELIX 1 AA1 PRO A 20 GLU A 25 1 6 HELIX 2 AA2 LYS A 31 VAL A 41 1 11 HELIX 3 AA3 MET A 50 LYS A 64 1 15 HELIX 4 AA4 ASP A 80 GLY A 87 1 8 HELIX 5 AA5 GLU A 95 ARG A 105 1 11 HELIX 6 AA6 PRO B 20 THR B 26 1 7 HELIX 7 AA7 LYS B 31 VAL B 41 1 11 HELIX 8 AA8 MET B 50 LYS B 64 1 15 HELIX 9 AA9 ASP B 80 GLY B 87 1 8 HELIX 10 AB1 GLU B 95 ASN B 106 1 12 HELIX 11 AB2 PRO C 20 GLU C 25 1 6 HELIX 12 AB3 LYS C 31 SER C 40 1 10 HELIX 13 AB4 MET C 50 ARG C 65 1 16 HELIX 14 AB5 ASP C 80 GLY C 87 1 8 HELIX 15 AB6 GLU C 95 ARG C 105 1 11 HELIX 16 AB7 PRO D 20 THR D 26 1 7 HELIX 17 AB8 LYS D 31 SER D 40 1 10 HELIX 18 AB9 MET D 50 ARG D 65 1 16 HELIX 19 AC1 ASP D 80 GLY D 87 1 8 HELIX 20 AC2 GLU D 95 ARG D 105 1 11 HELIX 21 AC3 PRO E 20 THR E 26 1 7 HELIX 22 AC4 LYS E 31 SER E 40 1 10 HELIX 23 AC5 MET E 50 ARG E 65 1 16 HELIX 24 AC6 ASP E 80 GLY E 87 1 8 HELIX 25 AC7 GLU E 95 ASN E 106 1 12 HELIX 26 AC8 LYS F 31 SER F 40 1 10 HELIX 27 AC9 MET F 50 ARG F 65 1 16 HELIX 28 AD1 ASP F 80 GLY F 87 1 8 HELIX 29 AD2 HIS F 96 ARG F 105 1 10 SHEET 1 AA1 3 TYR A 48 THR A 49 0 SHEET 2 AA1 3 LEU A 27 PRO A 30 -1 N VAL A 28 O TYR A 48 SHEET 3 AA1 3 LEU A 107 VAL A 109 -1 O VAL A 108 N ARG A 29 SHEET 1 AA2 2 ILE A 74 TYR A 76 0 SHEET 2 AA2 2 SER A 90 SER A 92 -1 O PHE A 91 N VAL A 75 SHEET 1 AA3 3 TYR B 48 THR B 49 0 SHEET 2 AA3 3 LEU B 27 PRO B 30 -1 N VAL B 28 O TYR B 48 SHEET 3 AA3 3 LEU B 107 VAL B 109 -1 O VAL B 108 N ARG B 29 SHEET 1 AA4 3 TYR B 67 ASP B 68 0 SHEET 2 AA4 3 GLN B 71 TYR B 76 -1 O GLN B 71 N ASP B 68 SHEET 3 AA4 3 SER B 90 SER B 92 -1 O PHE B 91 N VAL B 75 SHEET 1 AA5 3 TYR C 48 THR C 49 0 SHEET 2 AA5 3 LEU C 27 PRO C 30 -1 N VAL C 28 O TYR C 48 SHEET 3 AA5 3 LEU C 107 VAL C 109 -1 O VAL C 108 N ARG C 29 SHEET 1 AA6 2 ILE C 74 TYR C 76 0 SHEET 2 AA6 2 SER C 90 SER C 92 -1 O PHE C 91 N VAL C 75 SHEET 1 AA7 2 LEU D 27 VAL D 28 0 SHEET 2 AA7 2 TYR D 48 THR D 49 -1 O TYR D 48 N VAL D 28 SHEET 1 AA8 2 ILE D 74 TYR D 76 0 SHEET 2 AA8 2 SER D 90 SER D 92 -1 O PHE D 91 N VAL D 75 SHEET 1 AA9 3 TYR E 48 THR E 49 0 SHEET 2 AA9 3 LEU E 27 PRO E 30 -1 N VAL E 28 O TYR E 48 SHEET 3 AA9 3 LEU E 107 VAL E 109 -1 O VAL E 108 N ARG E 29 SHEET 1 AB1 2 ILE E 74 TYR E 76 0 SHEET 2 AB1 2 SER E 90 SER E 92 -1 O PHE E 91 N VAL E 75 SHEET 1 AB2 2 LEU F 27 VAL F 28 0 SHEET 2 AB2 2 TYR F 48 THR F 49 -1 O TYR F 48 N VAL F 28 SHEET 1 AB3 2 VAL F 75 TYR F 76 0 SHEET 2 AB3 2 SER F 90 PHE F 91 -1 O PHE F 91 N VAL F 75 SITE 1 AC1 3 GLN A 71 GLN A 72 HIS A 73 SITE 1 AC2 4 PRO A 20 ALA A 21 SER A 22 LYS A 36 SITE 1 AC3 5 LYS A 45 GLU A 52 HOH A 316 THR B 26 SITE 2 AC3 5 TYR B 104 SITE 1 AC4 5 SER A 17 GLN A 18 ILE A 19 GLN A 24 SITE 2 AC4 5 HIS A 96 SITE 1 AC5 12 LEU A 54 GLY A 58 ILE A 61 TYR A 67 SITE 2 AC5 12 GLN A 72 PHE A 86 VAL A 93 HIS A 96 SITE 3 AC5 12 ILE A 99 HOH A 302 GLU C 69 GLN C 72 SITE 1 AC6 2 ASP B 46 THR B 47 SITE 1 AC7 10 LEU B 54 GLY B 58 ILE B 61 MET B 62 SITE 2 AC7 10 TYR B 67 GLN B 72 PHE B 86 VAL B 93 SITE 3 AC7 10 HIS B 96 ILE B 99 SITE 1 AC8 5 GLN C 18 ILE C 19 GLN C 24 HIS C 96 SITE 2 AC8 5 6SS C 202 SITE 1 AC9 12 LEU C 54 GLY C 58 ILE C 61 MET C 62 SITE 2 AC9 12 TYR C 67 GLN C 72 PHE C 86 VAL C 93 SITE 3 AC9 12 HIS C 96 ILE C 99 GOL C 201 HOH C 307 SITE 1 AD1 5 SER D 17 GLN D 18 ILE D 19 GLN D 24 SITE 2 AD1 5 HIS D 96 SITE 1 AD2 11 LEU D 54 GLY D 58 ILE D 61 MET D 62 SITE 2 AD2 11 TYR D 67 GLN D 72 PHE D 86 VAL D 93 SITE 3 AD2 11 HIS D 96 ILE D 99 HOH D 305 SITE 1 AD3 1 6SS E 203 SITE 1 AD4 3 LYS E 45 ASP E 46 THR E 47 SITE 1 AD5 9 LEU E 54 GLY E 58 ILE E 61 TYR E 67 SITE 2 AD5 9 PHE E 86 VAL E 93 HIS E 96 ILE E 99 SITE 3 AD5 9 GOL E 201 SITE 1 AD6 7 LEU F 54 GLY F 58 ILE F 61 MET F 62 SITE 2 AD6 7 TYR F 67 HIS F 96 ILE F 99 CRYST1 71.450 71.450 520.977 90.00 90.00 120.00 P 65 2 2 72 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013996 0.008080 0.000000 0.00000 SCALE2 0.000000 0.016161 0.000000 0.00000 SCALE3 0.000000 0.000000 0.001919 0.00000